Fabino Enterprises Open Offer 2026: ₹20 Price, Key Dates

What the open offer is and why it matters

Fabino Enterprises Limited has announced a mandatory open offer to acquire 26.00% of its equity share capital. The tendering period opens on June 29, 2026 and closes on July 10, 2026. The offer price has been set at ₹20 per fully paid-up equity share. The acquirers named in the filing are R G Family Trust, Sameer Gupta, and Sundeep Gupta. The transaction follows a prior agreement to buy 56.82% of the company from the promoters through a Share Purchase Agreement (SPA). For public shareholders, the open offer sets a defined exit price and a clear timetable.

Key terms: size, price, and share details

The open offer is for 5,46,000 fully paid-up equity shares of Fabino Enterprises Limited. Each equity share has a face value of ₹10. The offer represents 26.00% of the company’s equity share capital, as stated in the open offer details. The offer price is ₹20 per share, implying a total consideration of ₹10.92 crore for the shares sought under the open offer. The company’s shares were cited at ₹20.31 on BSE as on April 27, 2026 (12:34 IST) in the provided market snapshot.

Who is running the process

Aryaman Financial Services Limited has been appointed as the manager to the offer. The open offer is being made by the acquirers R G Family Trust, Sameer Gupta, and Sundeep Gupta. The filings also state that funding for the offer is secured through internal resources and an escrow account. These details matter because they indicate the mechanism through which the acquirers plan to meet settlement obligations for accepted shares.

IDC view on valuation: why ₹20 was called fair

The Independent Directors Committee (IDC) of Fabino Enterprises Limited has determined that the offer price is “fair and reasonable,” as stated in the disclosure. The IDC cited market data showing the volume-weighted average market price (VWAP) on the BSE for the 60 trading days preceding the public announcement was ₹15.74 per share. The negotiated SPA price for acquisition under the Share Purchase Agreement was ₹18.00 per share. Against these reference points, the open offer price is ₹20 per share.

Dates that shareholders should track

The identified date for determining eligible shareholders is June 12, 2026. The Letter of Offer was dispatched electronically to shareholders on June 12, 2026 and physically on or before June 19, 2026. The offer opens on June 29, 2026 and closes on July 10, 2026, based on the revised schedule. Payment for accepted shares is scheduled within 10 working days from the closing date, specifically by July 24, 2026. The revised schedule also lists July 24, 2026 as the date of communicating rejection or acceptance.

Revised schedule: what changed

The filing includes an “Original Schedule” and “Revised Schedule” for key milestones. While the early steps such as the public announcement and the detailed public statement remained unchanged, the offer opening and closing dates were moved later. This type of revision is typically important for shareholders planning operational steps such as broker instructions and documentation readiness.

How to tender shares: demat and physical routes

Shareholders can tender shares in dematerialized form through their respective selling brokers. Shareholders holding physical shares can also tender via their selling broker, along with Form SH-4, as stated in the offer instructions. The current market lot for the offer is 3,000 equity shares. These operational details are relevant because open offer participation is broker-mediated and time-bound, and the process varies depending on whether shares are held in demat or physical form.

Company snapshot and identifiers

Fabino Enterprises Limited is described as an India-based pharmaceutical company engaged in manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-focused consumer products. Its core business includes marketing pharmaceutical formulations in the domestic market under its own brand name, with ayurvedic formulations manufactured through loan licensing facilities, and supported by packing and labeling. The disclosure also notes exports of wellness and FMCG products such as coffee, malt powder, protein powder, and hair shampoo.

The stock symbol is 543444 on the BSE and the ISIN is INE0DRT01018. The company’s market capitalisation was cited at ₹5.15 crore as on April 27, 2026. The company name change from “Fabino Life Sciences Limited” to “Fabino Enterprises Limited” was stated to be effective June 18, 2024.

Key figures at a glance

The numbers in the offer document help investors compare the offer price with recent market references and the negotiated SPA price.

Market impact and what investors should watch

The open offer fixes a tender price of ₹20 per share and provides a defined window for shareholders who want to participate. The IDC’s fairness view, backed by the 60-day VWAP of ₹15.74 and the SPA price of ₹18.00, frames the rationale used in the filings. Investors tracking the process may focus on operational milestones such as acceptance communication and the July 24, 2026 payment schedule. Shareholders also need to align tendering decisions with the market lot of 3,000 equity shares and the tendering route depending on demat or physical holdings.

Conclusion

Fabino Enterprises’ mandatory open offer for 26% stake at ₹20 per share opens June 29, 2026 and closes July 10, 2026, with acceptance communication and payout scheduled for July 24, 2026. The manager to the offer is Aryaman Financial Services Limited, and the IDC has termed the offer price fair based on disclosed market and SPA reference prices. The next key events for shareholders are the tendering window and the post-closing settlement timeline.